Cardio Diagnostics Holdings Stock Current Valuation
| CDIOW Stock | USD 0.1 0 2.10% |
Valuation analysis of Cardio Diagnostics helps investors to measure Cardio Diagnostics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Cardio Diagnostics' price fluctuation is out of control at this time. Calculation of the real value of Cardio Diagnostics is based on 3 months time horizon. Increasing Cardio Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cardio stock is determined by what a typical buyer is willing to pay for full or partial control of Cardio Diagnostics Holdings. Since Cardio Diagnostics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cardio Stock. However, Cardio Diagnostics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0979 | Real 0.074 | Hype 0.11 | Naive 0.1 |
The intrinsic value of Cardio Diagnostics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cardio Diagnostics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cardio Diagnostics Holdings helps investors to forecast how Cardio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cardio Diagnostics more accurately as focusing exclusively on Cardio Diagnostics' fundamentals will not take into account other important factors: Cardio Diagnostics Holdings Company Current Valuation Analysis
Cardio Diagnostics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Cardio Diagnostics Holdings has a Current Valuation of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Cardio Diagnostics Holdings is currently under evaluation in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 79.97 Million. Cardio Diagnostics adds roughly 0.0 in current valuation claiming only tiny portion of equities under Health Care industry.Cardio Fundamentals
| Return On Equity | -2.93 | ||||
| Return On Asset | -0.98 | ||||
| Operating Margin | (162.96) % | ||||
| Number Of Shares Shorted | 13.02 K | ||||
| Revenue | 17.07 K | ||||
| EBITDA | (1.53 M) | ||||
| Net Income | (8.38 M) | ||||
| Total Debt | 1.26 M | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (5.67 M) | ||||
| Beta | 4.68 | ||||
| Total Asset | 4.46 M | ||||
| Retained Earnings | (14.37 M) | ||||
| Working Capital | 1.92 M | ||||
| Net Asset | 4.46 M |
About Cardio Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cardio Diagnostics Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardio Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardio Diagnostics Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cardio Stock Analysis
When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.